ELEVAI Labs, Inc Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ fell 0.69% to 14,869.02. The S&P 500 also fell, dropping, 0.53% to 4,758.60.
Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio, Inc. (NASDAQ:INMB).
Elevai Labs, Inc. (ELAB) shares surged 50% after the company signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio, Inc.